In this context, pMMR CRC, with a median TMB of 4 mutations/MB, is defined as a low TMB tumor [35•], with a poor load of cancer specific antigens to be detected by cytotoxic CD8+ T cells, further explaining ICIs inefficacy in this CRC subgroup [18, 36]. The gene discussed is CD8A; the disease is colorectal carcinoma.